infliximab-axxq
E851093
Infliximab-axxq is a monoclonal antibody biosimilar to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
Statements (24)
| Predicate | Object |
|---|---|
| instanceOf |
biologic medicinal product
ⓘ
biosimilar medicinal product ⓘ monoclonal antibody ⓘ |
| belongsToGroup |
TNF inhibitors
NERFINISHED
ⓘ
biologic disease-modifying antirheumatic drugs ⓘ |
| biosimilarTo | infliximab NERFINISHED ⓘ |
| hasBiosimilarRelationship |
highly similar to reference infliximab
ⓘ
no clinically meaningful differences in safety and effectiveness compared with reference infliximab ⓘ |
| hasDrugClass | tumor necrosis factor alpha inhibitor ⓘ |
| hasMolecularType | chimeric monoclonal antibody ⓘ |
| hasTarget | tumor necrosis factor alpha NERFINISHED ⓘ |
| indicatedFor |
moderate to severe Crohn’s disease
ⓘ
moderate to severe rheumatoid arthritis ⓘ moderate to severe ulcerative colitis ⓘ |
| isIntendedUse | chronic systemic therapy ⓘ |
| mechanismOfAction |
binds to soluble and transmembrane TNF-alpha
ⓘ
neutralizes biological activity of TNF-alpha ⓘ |
| routeOfAdministration | intravenous ⓘ |
| therapeuticEffect |
reduces inflammation
ⓘ
suppresses immune response ⓘ |
| usedFor |
Crohn’s disease
ⓘ
autoimmune inflammatory diseases ⓘ rheumatoid arthritis ⓘ ulcerative colitis ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.